AWM
JAZZ icon

Adams Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Adams Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4
Closed -$1K – 201
2020
Q3 		$1K Buy
+4
New +$496 ﹤0.01% 318
2020
Q2 		– Sell
-3,006
Closed -$300K – 85
2020
Q1 		$300K Sell
3,006
-635
-17% -$82.1K 0.38% 47
2019
Q4 		$544K Buy
+3,641
New +$495K 0.46% 56

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Adams Wealth Management's JAZZ Position: Q4 2020 in Review

Adams Wealth Management sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2020, closing a stake of 4 shares — an estimated $1K sold.

Adams Wealth Management first reported a position in JAZZ in Q4 2019 and held it in 3 quarters. The position peaked at $544K in Q4 2019. 437 funds tracked by Wall St. Rank hold JAZZ as of Q4 2020.

  • Adams Wealth Management reported no remaining Jazz Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Adams Wealth Management sold 4 Jazz Pharmaceuticals shares in Q4 2020, an estimated $1K.
  • Adams Wealth Management first reported a position in Jazz Pharmaceuticals in Q4 2019 and held it in 3 quarters.
  • Adams Wealth Management's Jazz Pharmaceuticals position peaked at $544K in Q4 2019.
  • 437 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2020.

Based on Adams Wealth Management's 13F filing for Q4 2020, filed 8 Feb 2021.